Solasia Pharma

Basic Information

Stock Code
4597
Industry
Pharmaceuticals
Category Detail
Pharmaceuticals & Medical Products Wholesalers
Prefecture
Tokyo
Establishment Year
January 2007
Listing Year
March 2017
Official Website
https://solasia.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Alfresa Holdings, Hokuyaku Takeyama Holdings, Vital KSK Holdings, Cosmo Bio, Ooki Healthcare Holdings, Mobcast, Medorex, Brightpass, Medipal Holdings, Astena Holdings, Toho Holdings, KOA Shoji Holdings, Suzuken

Overview

Solasia Pharma is a pharmaceutical company established in 2007, specializing in the development of new anticancer drugs as its main business and expanding into the Asian market, including China, as a growing enterprise.

Current Situation

Solasia Pharma focuses on new drug development centered on anticancer agents and has been strengthening its sales base in China in recent years. Sales for fiscal 2023 are estimated at around 5 billion yen, and it continues to invest in research and development. It also operates a clinical trial consignment business and is diversifying while taking on a role in pharmaceutical distribution. It aims to create new drug candidates and provide therapeutic drugs toward technological innovation, while strengthening its sales capabilities to meet medical needs in Asia. In terms of sustainability, it promotes environmental burden reduction and ethical medical research, planning to enhance sustainable corporate value. In the future, it positions global market expansion and advancement of research technologies as growth drivers. In terms of fundraising, it is strengthening its financial position through stock acquisition rights issuance and capital reduction, continuing solid management operations. Points of caution include technological competition with competitors and fluctuations in the market environment for therapeutic drug development.

Trivia

Interesting Facts

  • Core player among Japanese companies engaged in new drug development centered on anticancer agents.
  • Early entry into pharmaceutical sales in China market and accumulated track record.
  • Multiple anticancer drug candidates in phased clinical trials.
  • Possesses unique know-how in bio-pharmaceutical manufacturing technology.
  • High regulatory compliance capability is a strength in clinical trial outsourcing operations.
  • Highly evaluated in the industry for clinical data analysis and management technology.
  • Diverse partnerships with pharmaceutical companies in Japan and abroad.
  • Utilized capital increases such as stock acquisition rights issuance in past fundraising.
  • Relatively new founding but rapidly growing emerging pharmaceutical company.
  • Multiple sales bases in China for regionally integrated deployment.
  • Business model fusing pharmaceutical wholesaling and R&D.
  • Also engages in joint operations of international clinical trials.
  • Maintains advanced quality control system.
  • Possesses system of multidisciplinary teams for pharmaceutical development.
  • Efficient patient recruitment through proprietary clinical trial support program.

Hidden Connections

  • Established strategic alliances with major Chinese wholesalers to secure market superiority.
  • Promotes technology exchange through joint research with domestic and foreign pharmaceutical ventures.
  • Strengthens clinical trial subject recruitment and clinical trial support through collaboration with medical institutions.
  • Advances basic research for new drug development in partnership with public research institutions.
  • Deploys clinical data management services linked with medical information technology companies.
  • Forms networks through educational programs for regional medical personnel.
  • Achieves efficient logistics and sales through collaboration with supply chain management companies.
  • Some subsidiaries handle bio-pharmaceutical manufacturing, realizing integrated system from manufacturing to sales.

Future Outlook

Growth Drivers

  • Global expansion of anticancer drug demand
  • Strengthening sales base in China and Asian markets
  • Introduction of advanced technologies for new drug development
  • Growth in clinical trial and clinical study outsourcing businesses
  • Enhancement of global regulatory compliance capabilities
  • Expansion of bio-pharmaceutical manufacturing support
  • Technological innovation for pharmaceutical distribution efficiency
  • Stabilization of revenue base through diversified businesses
  • Improved corporate evaluation through sustainability measures
  • Expansion of medical information services market
  • New business development through partnership expansion
  • Improved development efficiency through AI and digital technology utilization

Strategic Goals

  • Expansion and commercialization of anticancer drug development pipeline
  • Double current sales in China market
  • Enter top 5 in Asian market for clinical trial outsourcing business
  • Establishment and practice of sustainable pharmaceutical production standards
  • Advanced bio-manufacturing equipment and doubled production capacity
  • Significant growth in medical information and IT services business
  • Expansion of diverse sales channels and promotion of digitalization
  • Further expansion of regional medical support activities
  • Diversification of new fundraising methods and strengthening of management base
  • Acceleration of new technology development utilizing advanced technologies

Business Segments

New Drug Development Support

Overview
Supports customers' research and development through new drug development centered on anticancer agents and clinical trial outsourcing.
Competitiveness
Integration of sales networks and research technologies centered on China
Customers
  • Domestic pharmaceutical companies
  • Foreign pharmaceutical companies
  • Biotechnology companies
  • Companies entering Asian markets
  • Research institutions
  • Medical institutions
  • Clinical trial facilities
  • CRO companies
  • SMO companies
  • Pharmaceutical development consultants
Products
  • Anticancer drug development
  • Clinical trial protocol development
  • Clinical trial operational support
  • Pharmaceutical safety evaluation
  • Data management systems
  • Regulatory compliance support
  • Biomarker analysis
  • Drug efficacy analysis
  • Market research
  • Therapeutic drug sales promotion

Pharmaceutical Distribution

Overview
Handles pharmaceutical wholesaling and logistics mainly in China, achieving distribution efficiency and quality control.
Competitiveness
Rapid supply capability through local sales bases
Customers
  • Hospitals
  • Pharmacies
  • Medical wholesalers
  • Drugstores
  • Chinese pharmaceutical sales companies
  • Pharmaceutical agents in various countries
  • Hospital groups
  • Telemedicine services
  • Health management facilities
  • Specialized treatment centers
Products
  • Anticancer drug wholesaling
  • Medical supplies
  • Therapeutic drug delivery
  • Inventory management systems
  • Logistics services
  • Sales promotion tools
  • Pharmaceuticals for Chinese market
  • Clinical trial drug supply
  • Pharmacy support services
  • Patient follow-up

Clinical Trial Outsourcing

Overview
Provides a wide range of services from consignment, management, to analysis of clinical trials upon request from pharmaceutical companies, etc.
Competitiveness
Strict regulatory compliance and extensive experience with domestic and international cases
Customers
  • Pharmaceutical companies
  • Bio ventures
  • Medical institutions
  • Clinical trial facilities
  • Public research institutions
  • CRO
  • SMO
  • Regulatory agencies
  • Clinical research organizations
  • Patient groups
Products
  • Clinical trial planning
  • Clinical trial management
  • Data analysis
  • Regulatory compliance support
  • Patient recruitment support
  • Safety evaluation
  • Report preparation
  • Quality management
  • Risk management
  • Monitoring

Medical Equipment Related Business

Overview
Supports efficiency in medical settings through sales and support of medical equipment.
Competitiveness
Total solution provision linked with pharmaceuticals
Customers
  • Hospitals
  • Clinics
  • Medical equipment sales companies
  • Testing centers
  • Healthcare companies
  • Medical consultants
  • Orthopedic clinics
  • Nursing homes
  • Rehabilitation centers
  • Health checkup institutions
Products
  • Testing equipment sales
  • Maintenance services
  • Medical data management
  • Diagnostic support tools
  • Training services
  • Testing reagents
  • Telemedicine equipment
  • Health monitoring systems
  • Safety management systems
  • IT solutions

R&D Outsourcing

Overview
Provides diverse support and technology for outsourced research and development.
Competitiveness
Advanced support system leveraging knowledge in pharmaceuticals and distribution
Customers
  • Pharmaceutical companies
  • Bio companies
  • University labs
  • Public research institutions
  • Contract research organizations
  • CRO
  • Medical ventures
  • Technology development companies
  • Formulation development companies
  • Investment fund-related companies
Products
  • Reagent development
  • Bioanalysis
  • Formulation design support
  • Project management
  • Intellectual property research
  • Data analysis support
  • Drug efficacy evaluation
  • Safety testing
  • Technology transfer support
  • Preclinical research

Bio-Pharmaceutical Manufacturing Support

Overview
Supports bio-pharmaceutical manufacturing technology and process development to improve productivity.
Competitiveness
Introduction of latest technologies and China market responsiveness
Customers
  • Bio-pharmaceutical companies
  • Pharmaceutical companies
  • Research institutions
  • Cell therapy ventures
  • Gene therapy developers
  • Medical device manufacturers
  • Contract manufacturing companies
  • Quality control institutions
  • Regulatory authorities
  • Measurement equipment sales companies
Products
  • Bio-formulation manufacturing
  • Quality control
  • Manufacturing process design
  • Cell culture technology
  • Equipment leasing
  • Manufacturing consignment
  • Product inspection
  • Production efficiency support
  • Safety evaluation
  • Regulatory compliance

Medical Information Services

Overview
Deploys information technology services useful for medical sites and pharmaceutical businesses.
Competitiveness
Abundant clinical trial data and information network
Customers
  • Hospitals
  • Clinics
  • Pharmaceutical companies
  • Medical device manufacturers
  • Insurance companies
  • Government agencies
  • Medical research institutes
  • Patient support groups
  • Medical IT vendors
  • Data analysis companies
Products
  • Medical data analysis tools
  • Clinical trial data management
  • Patient monitoring
  • Information provision services
  • Electronic medical records integration
  • Teleconsultation support
  • Pharmaceutical information provision
  • Regulatory information management
  • Market reports
  • Safety tracking

Logistics and Supply Chain Solutions

Overview
Provides technologies and services to improve efficiency across pharmaceutical logistics and supply networks.
Competitiveness
High-quality temperature control technology and rapid delivery network
Customers
  • Pharmaceutical companies
  • Distributors
  • Medical institutions
  • Research institutions
  • Government agencies
  • CRO
  • Wholesalers
  • Drugstores
  • Formulation factories
  • International transport companies
Products
  • Pharmaceutical logistics management
  • Inventory optimization
  • Delivery services
  • Warehouse management
  • Temperature-controlled logistics
  • Traceability
  • Supply chain improvement
  • Risk management
  • Export/import support
  • Logistics IT

China Market Expansion Support

Overview
Provides comprehensive support services necessary for entering the Chinese market.
Competitiveness
Extensive local network and regulatory expertise
Customers
  • Japanese pharmaceutical companies
  • Chinese pharmaceutical companies
  • Distributors
  • Agents
  • Marketing companies
  • Regulatory consultants
  • Market research companies
  • Legal services
  • Logistics companies
  • Local investors
Products
  • Local agency operations
  • Regulatory compliance support
  • Marketing strategies
  • Sales promotion programs
  • Clinical trial coordination
  • Distribution channel development
  • Quality control
  • Intellectual property protection
  • Market information provision
  • Business matching

Education and Training for Medical Institutions

Overview
Educational services aimed at skill improvement for medical professionals and dissemination of new drug knowledge.
Competitiveness
Specialized training curriculum based on practical experience
Customers
  • Physicians
  • Nurses
  • Medical technicians
  • Pharmacists
  • Clinical trial coordinators
  • Clinical researchers
  • Manufacturer sales representatives
  • Educational institutions
  • Academic societies
  • Medical corporations
Products
  • Anticancer drug treatment training
  • Clinical trial-related education
  • Pharmaceutical safety management training
  • Clinical research regulations training
  • Data management training
  • Treatment technology updates
  • Regulatory compliance training
  • Marketing training
  • Ethics education
  • Patient response skills courses

Pharmaceutical Safety Management and Regulatory Compliance

Overview
Supports strengthening of safety management systems for pharmaceutical and medical companies.
Competitiveness
Information network on latest regulations and experienced staff
Customers
  • Pharmaceutical companies
  • Medical institutions
  • CRO
  • SMO
  • Regulatory authorities
  • Research institutions
  • Distributors
  • Manufacturers
  • Insurance companies
  • Clinical research organizations
Products
  • Adverse event reporting support
  • Safety monitoring
  • Regulatory revision response
  • Quality assurance
  • Risk assessment
  • Product recall response
  • Audit support
  • Corrective actions
  • Document management
  • Training programs

Competitive Advantage

Strengths

  • Technology specialized in new drug development
  • Strong sales network in China market
  • Diverse clinical trial outsourcing track record
  • Expansion of sales bases across Asia
  • Advanced pharmaceutical distribution management system
  • Flexible fundraising structure
  • Abundant strategic partners
  • Strength in clinical data collection
  • Global regulatory compliance capabilities
  • Rapid market launch system
  • Bio-pharmaceutical manufacturing support technology
  • Expertise in medical information services
  • Abundant R&D personnel
  • Network for clinical trial patient recruitment
  • Thorough regulatory compliance

Competitive Advantages

  • One of the few Japanese new drug development companies with sales bases in China
  • Strength in anticancer agents and development of unique drug lineup
  • Risk diversification through diversified businesses in clinical trial outsourcing and pharmaceutical wholesaling
  • Established business model fusing R&D and distribution
  • Organizational structure capable of rapid response to multinational pharmaceutical regulations
  • Good relationship with China National Medical Products Administration (NMPA)
  • Numerous success cases in therapeutic drug development using advanced technologies
  • Strategic marketing power in Asian markets
  • Abundant experience and know-how in clinical trial operations
  • Strong network and track record in local sales
  • Strict quality control system and certifications
  • Utilization of expanding bio-pharmaceutical manufacturing facilities
  • Broad service deployment accommodating diverse customer segments
  • Ongoing long-term R&D plans and investments
  • Development and manufacturing systems compliant with industry standards

Threats

  • Development delays due to intense technological competition
  • Regulatory fluctuations in overseas markets including China
  • Risk of increased fundraising costs
  • Market pressure from new entries by competitors
  • Decrease in adaptation opportunities due to diversification of treatments
  • Risks of delays or denials in new drug approvals
  • Impact of global political and economic situations
  • Intellectual property infringement risks
  • Changes in demand due to emergence of new diseases
  • Decline in profitability due to exchange rate fluctuations
  • Supply chain disruption risks
  • Difficulties in clinical trial patient recruitment

Innovations

2024: Start of Clinical Trials for New Anticancer Molecular Entity

Overview
Initiated Phase 2 clinical trials for an innovative molecular targeted therapeutic drug in China.
Impact
Expected expansion of treatment options and market growth

2023: Introduction of Clinical Trial Data Management Platform

Overview
Introduced an efficient clinical data management system utilizing digital technology.
Impact
Shortened trial periods and improved data quality

2022: Established New Base to Expand Sales Network in China

Overview
Installed new sales bases in major Chinese cities to strengthen sales capabilities.
Impact
Improved market share and sales expansion

2021: Acceleration of Next-Generation Treatment Research and Development

Overview
Focusing on immunotherapy and cell therapy research to advance development of new candidate drugs.
Impact
Strengthening long-term growth foundation

2020: Introduction of Environmentally Friendly Pharmaceutical Processes

Overview
Introduced technologies to reduce environmental burden in production processes, achieving energy savings.
Impact
Reduced environmental burden and improved cost efficiency

2024: Strengthened Clinical Trial Patient Recruitment Support Program

Overview
Expanded support programs and collaboration systems to improve patient recruitment efficiency.
Impact
Improved clinical trial speed and reduced development risks

2023: Renewal of Pharmaceutical Safety Monitoring System

Overview
Advanced the adverse event monitoring system to enable rapid responses.
Impact
Improved product safety and gained trust

2022: Innovation in Bio-Pharmaceutical Manufacturing Technology

Overview
Introduced technologies for manufacturing process efficiency and quality improvement.
Impact
30% productivity improvement and enhanced product quality

2021: Efficiency Improvement in Pharmaceutical Development Using AI

Overview
Introduced AI technology to accelerate new drug candidate exploration and optimization.
Impact
Shortened development periods and cost reductions

2020: Start of Adoption of Sustainable Packaging Materials

Overview
Introduced recyclable packaging materials to reduce environmental burden.
Impact
Reduced environmental burden and improved corporate image

Sustainability

  • Adopting energy-saving manufacturing processes to reduce environmental burden
  • Reducing plastics through introduction of recyclable packaging materials
  • Strengthening pharmaceutical safety and advancing adverse event monitoring
  • Ethical clinical trial implementation and patient rights protection
  • Active participation in regional medical support and health promotion activities
  • Obtained certifications for environmental burden reduction in manufacturing equipment
  • Implementing employee health promotion programs
  • Efforts to improve transparency in supply chains
  • Launch of product recycling programs
  • Formulation of policies for sustainable raw material procurement